{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T19:21:46Z","timestamp":1648754506421},"reference-count":41,"publisher":"Japan Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1507\/endocrj.k10e-198","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T10:23:22Z","timestamp":1286965402000},"page":"1071-1079","source":"Crossref","is-referenced-by-count":1,"title":["Is there an undiscovered neurocircuit for regulating GH secretion? -Pitfalls of GHRP-2 and ITT as GH provocative tests-"],"prefix":"10.1507","volume":"57","author":[{"given":"Kyuzi","family":"Kamoi","sequence":"first","affiliation":[{"name":"The Center of Diabetes and Endocrine & Metabolism Disease, Nagaoka Red Cross Hospital, Nagaoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shimatsu","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Physical Therapy, Seiryo Rehabilitation College, Nagaoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gahete MD, Dur&aacute;n-Prado M, Luque RM, Mart&iacute;nez-Fuentes AJ, Quintero A, Guti&eacute;rrez-Pascual E, C&oacute;rdoba-Chac&oacute;n J, Malag&oacute;n MM, Gracia-Navarro F, Casta&ntilde;o JP (2009) Understanding the multifactorial control of growth hormone release by somatotropes: lessons from comparative endocrinology.<i> Ann N Y Acad Sc<\/i> 1163: 137-153.","DOI":"10.1111\/j.1749-6632.2008.03660.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Muller EE, Locatelli V, Cocchi D (1999) Neuroendocrine control of growth hormone secretion. <i>Physiol Rev<\/i> 79: 511-607.","DOI":"10.1152\/physrev.1999.79.2.511"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Consensus guide lines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency (1998) <i>J Clin Endocrinol Metabol <\/i>83: 379-381.","DOI":"10.1210\/jc.83.2.379"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ho KK (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. <i>Eur J Endocrinol<\/i> 157: 695-700.","DOI":"10.1530\/EJE-07-0631"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-6-1187"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hader O, B&auml;hr V, Hensen J, Hofbauer KG, Oelkers WK (1990) Effects of a V1-vasopressin antagonist on ACTH release following vasopressin infusion or insulin-induced hypoglycemia in normal men. <i>Acta Endocrinol (Copenh) <\/i>123: 622-628.","DOI":"10.1530\/acta.0.1230622"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chiodera P, Gnudi A, Bianconi L, Camellini L, Rossi G, Muzzetto P, Fagnoni F, Schianchi L, Volpi R, Coiro V (1989) The infusion of somatostatin reduces the arginine-vasopressin response to insulin-induced hypoglycemia in man. <i>J Endocrinol Invest <\/i>12: 349-353.","DOI":"10.1007\/BF03350005"},{"key":"8","unstructured":"8. Bowers CY. Synergistic release of growth hormone by GHRP and GHRH: Scope and implication. In Growth Hormone Secretagogues in Clinical Practice, pp 1-25. Eds Bercu BB Walker RF. New York: Marcel Dekker, 1998."},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0066"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K09E-215"},{"key":"11","unstructured":"11. Quabbe HJ (1977) Chronobiology of growth hormone secretion. <i>Chronobiologia <\/i>4: 217-246."},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.46.269"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Consitt LA, Wideman L Hickey MS, Morrison RF (2008) Phosphorylation of the JAK2-STAT5 pathway in response to acute aerobic exercise. <i>Med Sci Sports Exerc <\/i>40: 1031-1038.","DOI":"10.1249\/MSS.0b013e3181690760"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Spathis GS, Bloom SR, Jeffcoate WJ, Millar JGB, Kurtz AZ, Pyasena MRD, Smith JA, Nabarro JDN (1974) Subcutaneous glucagon as a test of the ability of the pituitary to secrete GH and ACTH. <i>Clin Endocrinol <\/i>3: 175-186.","DOI":"10.1111\/j.1365-2265.1974.tb01793.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Berg C, Meinel T, Lahner H, Yuece A, Mannand K, Petersenn S (2010) Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery. <i>Eur J Endocrinol <\/i>162: 477-482.","DOI":"10.1530\/EJE-09-0824"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hattori N, Shimatsu A, Yamanaka C, Momoi T, Imura H (1988) Nocturnal urinary growth hormone excretion in children with short stature. <i>Acta Endocrinol (Copenh)<\/i> 119: 113-117.","DOI":"10.1530\/acta.0.1190113"},{"key":"17","unstructured":"17. Frohman LA (1995) Disease of anterior pituitary. In: Felig P, Baxter JD, Frohman LA (ed) Endocrinology and Metabolism 3rd ed. McGraw-Hill, New York: 289-384."},{"key":"18","unstructured":"18. Robertson GL (1995) Posterior pituitary. In: Felig P, Baxter JD, Frohman LA (ed) Endocrinology and Metabolism 3rd ed. McGraw-Hill, New York: 385-434."},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.315"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML (2002) Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. <i>J Clin Endocrinol Metab<\/i> 87: 2067-2079.","DOI":"10.1210\/jcem.87.5.8509"},{"key":"21","unstructured":"21. The Japan Endocrine Society (2010) Guideline of diagnosis and treatment for hypothalamopituitary disorders. http:\/\/square.umin.ac.jp\/endocrine."},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K07E-168"},{"key":"23","unstructured":"23. Veldhuis JD, Bowers CY (2009) Determinants of GH-releasing hormone and GH-releasing peptide synergy in men. <i>Am J Physiol Endocrinol Metab <\/i>296: E1085- 1092."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Qu XD, Gaw Gonzalo IT, Al Sayed MY, Cohan P, Christenson PD, Swerdloff RS, Kelly DF, Wang C (2005) Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests. <i>J Clin Endocrinol Metab <\/i> 90: 1563-1569.","DOI":"10.1210\/jc.2004-1450"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(92)90220-5"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Bonert VS, Elashoff JD, Barnett P, Melmed S (2004) Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. <i>J Clin Endocrinol Metab <\/i>89: 3397-3401.","DOI":"10.1210\/jc.2003-032213"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01967"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Gullstrand M, Ahr&eacute;n B, Wredling R, Backman L, Lins PE, Adamson U (2003) Alteration of the counterregulatory responses to insulin-induced hypoglycemia and of cognitive function after massive weight reduction in severely obese subjects. <i>Metabolism <\/i>52: 900-907.","DOI":"10.1016\/S0026-0495(03)00103-3"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb03793.x"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K10E-017"},{"key":"31","unstructured":"31. Doi N, Hirotani C, Ukai K, Shimada O, Okuno T, Kurasaki S, Kiyofuji T, Ikegami R, Futamata M, Nakagawa T, Ase K, Chihara K (2004) Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. <i>Arzneimittelforschung <\/i>54: 857-867."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Shimatsu A, Kato U, Matsushita N, Katakami H, Yanaihara N, Imura H (1982) Effects of glucagon, neurotensin, and vasoactive intestinal polypeptide on somatostatin release from perfused rat hypothalamus. <i>Endocrinology<\/i> 110: 2113-2117.","DOI":"10.1210\/endo-110-6-2113"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Katakami H, Kato Y, Matsushita N, Shimatsu A, Waseda N, Imura H (1984) Interrelation between somatostatin output from the mediobasal hypothalamus and plasma growth hormone levels in conscious rats: effects of glucagon administration. <i>Endocrinology<\/i> 115: 1598-1604.","DOI":"10.1210\/endo-115-4-1598"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Arvat E, Maccagno B, Ramunni J, Giordano R, Fabio Broglio F, Gianotti L, Maccario M, Camanni F, Ghigo F (2000) Interaction between glucagon and Hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans.<i> J Endocrinol <\/i>143: 601-606.","DOI":"10.1530\/eje.0.1430601"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Leong KS, Walker AB, Martin I, Wile D, Wilding J, MacFarlane IA (2001) An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease. <i>Clin Endocrinol (Oxf)<\/i> 54: 463-468.","DOI":"10.1046\/j.1365-2265.2001.01169.x"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2008.06.002"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Tannenbaum GS, Epelbaum J, Bowers CY (2003) Interrelationship between the novel peptide ghrelin and somatostatin\/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. <i>Endocrinology<\/i> 144(3): 967-974.","DOI":"10.1210\/en.2002-220852"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01530.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Millar RP, Klaff LJ, Barron JL, Levitt NS, Ling N (1983) Somatostatin-28 and somatostatin-14 suppression of arginine-, insulin-, and TRH-stimulated GH and PRL secretion in man. <i>Clin Endocrinol (Oxf)<\/i> 18: 277-285.","DOI":"10.1111\/j.1365-2265.1983.tb03212.x"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb00923.x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Bowers, CY, Sartor AO, Reynolds GA, Badger G (1991) On the action of the growth hormone-releasing hexapeptide, GHRP. <i>Endocrinology<\/i> 128: 2027-2035.","DOI":"10.1210\/endo-128-4-2027"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/57\/12\/57_K10E-198\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:54:19Z","timestamp":1618296859000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/57\/12\/57_K10E-198\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k10e-198","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}